Generalized Anxiety Disorder
Conditions
Interventions
Sponsors
Beijing An Ding Hospital, Capital Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1. Subjects who have signed the main trial informed consent form and have received at least one dose of the investigational product during or within the main trial period; 2. Be capable of fully understanding and signing the informed consent form for this extended observational study; 3. Subjects shall have no contraindications to venous blood collection, exhibit normal coagulation function, and be able to cooperate with the additional blood collection procedures scheduled at each visit.
Exclusion criteria
Exclusion criteria: 1. Subjects who have seriously violated the protocols of both the main trial and this observational study; 2. Subjects with severe anemia or coagulation disorders; 3. Other conditions judged by the investigator to render the subject ineligible for enrollment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Cortisol levels;Plasma levels of Corticotropin-Releasing Factor;Omics-related indicators;Adrenocorticotropic Hormone; | — |
Countries
China
Contacts
Public ContactGang Wang
Beijing An Ding Hospital, Capital Medical University
Outcome results
None listed